Institutions / Persistent Asset Partners Ltd / Activity
Activity — Persistent Asset Partners Ltd
1,188 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Trim | Sandisk Corp Common stock | $-37.94M | -17K -92.46% | 1,360 0.98% of portfolio | medium |
| Q2 2026 as of | Add | Robinhood Markets, Inc. Common stock | $18.50M | +184K +2787.07% | 191,095 6.05% of portfolio | medium |
| Q2 2026 as of | New | 861012102 Common stock | $16.90M | +226K | 225,636 5.33% of portfolio | medium |
| Q2 2026 as of | Trim | Centene Corp Common stock | $-14.08M | -219K -99.46% | 1,192 0.02% of portfolio | medium |
| Q2 2026 as of | New | Amphenol Corp /De Common stock | $13.31M | +76K | 75,502 4.20% of portfolio | medium |
| Q2 2026 as of | New | Seagate Technology Holdings PLC Common stock | $8.94M | +9K | 9,265 2.82% of portfolio | medium |
| Q2 2026 as of | Trim | Elevance Health Inc Common stock | $-8.91M | -23K -99.97% | 6 <0.01% of portfolio | medium |
| Q2 2026 as of | Exit | Molina Healthcare Inc Common stock | $-8.90M | -51K -100.00% | 0 | medium |
| Q4 2025 as of | New | Molina Healthcare Inc Common stock | $8.90M | +51K | 51,285 2.81% of portfolio | medium |
| Q2 2026 as of | New | Snowflake Inc. Common stock | $7.07M | +28K | 27,783 2.23% of portfolio | medium |
| Q2 2026 as of | Trim | Nebius Group N.V. Common stock | $-6.31M | -23K -76.16% | 7,153 0.62% of portfolio | medium |
| Q2 2026 as of | New | Ford Motor Co Common stock | $6.20M | +446K | 445,837 1.96% of portfolio | medium |
| Q2 2026 as of | Add | United Therapeutics Corp Common stock | $5.81M | +11K +327.95% | 13,981 2.39% of portfolio | medium |
| Q2 2026 as of | New | Applied Materials Inc /De Common stock | $5.62M | +8K | 7,780 1.77% of portfolio | medium |
| Q4 2025 as of | Add | Elevance Health Inc Common stock | $5.34M | +15K +195.14% | 23,039 2.55% of portfolio | medium |
| Q2 2026 as of | Exit | Axt Inc Common stock | $-5.03M | -308K -100.00% | 0 | medium |
| Q4 2025 as of | New | Axt Inc Common stock | $5.03M | +308K | 307,611 1.59% of portfolio | medium |
| Q2 2026 as of | New | Kla Corp Common stock | $4.96M | +16K | 16,442 1.57% of portfolio | low |
| Q4 2025 as of | Exit | 464287440 Common stock | $-4.82M | -50K -100.00% | 0 | low |
| Q2 2026 as of | Exit | Terns Pharmaceuticals, Inc. Common stock | $-4.59M | -114K -100.00% | 0 | low |
| Q4 2025 as of | New | Sandisk Corp Common stock | $4.28M | +18K | 18,047 1.35% of portfolio | low |
| Q2 2026 as of | New | Cadence Design Systems Inc Common stock | $4.17M | +11K | 11,111 1.32% of portfolio | low |
| Q4 2025 as of | Add | Intel Corp Common stock | $4.16M | +113K +352.63% | 144,840 1.69% of portfolio | low |
| Q2 2026 as of | Trim | Micron Technology Inc Common stock | $-4.02M | -3K -62.90% | 2,053 0.75% of portfolio | low |
| Q2 2026 as of | Add | Revolution Medicines, Inc. Common stock | $3.97M | +21K +120.82% | 38,726 2.29% of portfolio | low |
| Q2 2026 as of | Add | Intel Corp Common stock | $3.95M | +28K +19.52% | 173,113 7.63% of portfolio | low |
| Q4 2025 as of | New | Johnson & Johnson Common stock | $3.66M | +18K | 17,708 1.16% of portfolio | low |
| Q2 2026 as of | New | Semtech Corp Common stock | $3.54M | +22K | 21,849 1.12% of portfolio | low |
| Q2 2026 as of | Exit | BrightSpring Health Services, Inc. Common stock | $-3.52M | -94K -100.00% | 0 | low |
| Q2 2026 as of | Add | Cogent Biosciences, Inc. Common stock | $3.51M | +91K +191.11% | 138,272 1.69% of portfolio | low |
| Q2 2026 as of | New | Honeywell International Inc Common stock | $3.46M | +15K | 15,450 1.09% of portfolio | low |
| Q2 2026 as of | New | HONA Honeywell Aerospace Inc. Common Stock | $3.42M | +15K | 15,450 1.08% of portfolio | low |
| Q4 2025 as of | Trim | Regeneron Pharmaceuticals, Inc. Common stock | $-3.23M | -4K -60.48% | 2,731 0.67% of portfolio | low |
| Q2 2026 as of | Trim | NVIDIA Corp Common stock | $-3.16M | -16K -96.67% | 545 0.03% of portfolio | low |
| Q2 2026 as of | New | Western Digital Corp Common stock | $3.10M | +5K | 4,859 0.98% of portfolio | low |
| Q2 2026 as of | Trim | Johnson & Johnson Common stock | $-3.07M | -12K -68.35% | 5,605 0.45% of portfolio | low |
| Q4 2025 as of | Trim | Unitedhealth Group Inc Common stock | $-3.07M | -9K -77.07% | 2,766 0.29% of portfolio | low |
| Q4 2025 as of | Exit | 46438F101 Common stock | $-2.87M | -44K -100.00% | 0 | low |
| Q2 2026 as of | New | Littelfuse Inc /De Common stock | $2.70M | +6K | 5,927 0.85% of portfolio | low |
| Q2 2026 as of | Add | 00370M103 Common stock | $2.64M | +20K +81.28% | 44,256 1.86% of portfolio | low |
| Q4 2025 as of | Exit | Labcorp Holdings Inc. Common stock | $-2.58M | -9K -100.00% | 0 | low |
| Q2 2026 as of | Exit | Alphabet Inc. Common stock | $-2.53M | -8K -100.00% | 0 | low |
| Q4 2025 as of | New | Alphabet Inc. Common stock | $2.53M | +8K | 8,069 0.80% of portfolio | low |
| Q2 2026 as of | Add | Lam Research Corp Common stock | $2.50M | +6K +188.27% | 8,824 1.21% of portfolio | low |
| Q4 2025 as of | Add | 00370M103 Common stock | $2.34M | +15K +154.20% | 24,413 1.22% of portfolio | low |
| Q2 2026 as of | Add | BioMarin Pharmaceutical Inc Common stock | $2.33M | +41K +104.25% | 79,933 1.44% of portfolio | low |
| Q4 2025 as of | Trim | CVS HEALTH Corp Common stock | $-2.31M | -29K -56.48% | 22,431 0.56% of portfolio | low |
| Q4 2025 as of | Exit | Quest Diagnostics Inc Common stock | $-2.30M | -12K -100.00% | 0 | low |
| Q2 2026 as of | New | Onto Innovation Inc. Common stock | $2.25M | +6K | 5,947 0.71% of portfolio | low |
| Q2 2026 as of | New | KOD Kodiak Sciences Inc. Common Stock | $2.18M | +56K | 56,052 0.69% of portfolio | low |